European Journal of Preventive Cardiology

Papers
(The TQCC of European Journal of Preventive Cardiology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of th331
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study317
Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017232
Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19)216
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice185
Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study 126
The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiolo118
Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European A97
ABO blood group predisposes to COVID-19 severity and cardiovascular diseases91
Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the Euro85
Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic79
Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 Eu72
Personalized exercise prescription in the prevention and treatment of arterial hypertension: a Consensus Document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on H68
Effectiveness of home-based cardiac telerehabilitation as an alternative to Phase 2 cardiac rehabilitation of coronary heart disease: a systematic review and meta-analysis67
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular66
HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies65
Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure: A nationwide population-based cohort study63
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead62
Long-term follow-up with a smartphone application improves exercise capacity post cardiac rehabilitation: A randomized controlled trial59
Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction58
Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990–201957
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings52
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation48
Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis47
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial47
Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation programme: A position statement of the46
Sport and exercise during and beyond the COVID-19 pandemic45
Role of gender, age and BMI in prognosis of heart failure45
Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis41
Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic41
Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies39
Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing38
Physical exercise training in patients with a Fontan circulation: A systematic review37
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working 37
Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys36
Future-proofing cardiac rehabilitation: Transitioning services to telehealth during COVID-1936
Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation35
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions35
Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project35
Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis34
Obesity, overweight and risk for cardiovascular disease and mortality in young women33
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning33
Yield and clinical significance of genetic screening in elite and amateur athletes32
Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990−2019: findings from 2019 global burden of disease study31
Non-genetic risk factors for atrial fibrillation are equally important in both young and old age: A nationwide population-based study31
Effects of exercise rehabilitation in patients with long coronavirus disease 201931
Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management31
Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations31
Long-term cumulative blood pressure in young adults and incident heart failure, coronary heart disease, stroke, and cardiovascular disease: The CARDIA study30
Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid30
Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis30
Coffee consumption and mortality from cardiovascular diseases and total mortality: Does the brewing method matter?29
Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis29
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines29
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–201729
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy29
Combined use of trimethylamine N-oxide with BNP for risk stratification in heart failure with preserved ejection fraction: findings from the DIAMONDHFpEF study29
Association of four lipid components with mortality, myocardial infarction, and stroke in statin-naïve young adults: A nationwide cohort study28
C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism28
Age- and gender-specific upper limits and reference equations for workload-indexed systolic blood pressure response during bicycle ergometry28
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial28
Physical activity/inactivity and COVID-1927
Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study27
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system27
Detecting undiagnosed atrial fibrillation in UK primary care: Validation of a machine learning prediction algorithm in a retrospective cohort study27
Myocarditis in athletes: A clinical perspective27
Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective26
The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review26
Finding very high lipoprotein(a): the need for routine assessment26
Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise nucleus of the European26
Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy25
Cardiovascular disease and COVID-19: les liaisons dangereuses25
Home blood pressure during COVID-19-related lockdown in patients with hypertension25
Protective effects of SGLT-2 inhibitors across the cardiorenal continuum: two faces of the same coin25
Participation in exercise-based cardiac rehabilitation is related to reduced total mortality in both men and women: results from the SWEDEHEART registry25
Self-reported daytime napping, daytime sleepiness, and other sleep phenotypes in the development of cardiometabolic diseases: a Mendelian randomization study24
EAPC Core Curriculum for Preventive Cardiology24
Abdominal aortic calcification: from ancient friend to modern foe24
Multimodal prehabilitation as a promising strategy for preventing physical deconditioning on the heart transplant waiting list24
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry23
Improvements in exercise capacity of older adults during cardiac rehabilitation23
Obesity, overweight and survival in critically ill patients with SARS-CoV-2 pneumonia: is there an obesity paradox? Preliminary results from Italy23
Global magnitude and temporal trend of infective endocarditis, 1990–2019: results from the Global Burden of Disease Study23
Short-term effects of particulate matter on cardiovascular morbidity in Italy: a national analysis22
Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry22
Triglyceride–glucose index in the development of heart failure and left ventricular dysfunction: analysis of the ARIC study22
The effects of transitions in metabolic health and obesity status on incident cardiovascular disease: Insights from a general Chinese population22
Prognostic role of transferrin saturation in heart failure patients22
Mental health-related risk factors and interventions in patients with heart failure: a position paper endorsed by the European Association of Preventive Cardiology (EAPC)22
Trends in peripheral arterial disease incidence and mortality in EU15+ countries 1990–201722
Life’s Essential 8 and the risk of cardiovascular disease death and all-cause mortality in Finnish men22
Association of short-term exposure to air pollution with myocardial infarction with and without obstructive coronary artery disease22
European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with t22
Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease22
Global, regional, and national quality of care of ischaemic heart disease from 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 201722
Cardiac rehabilitation of elderly patients in eight rehabilitation units in western Europe: Outcome data from the EU-CaRE multi-centre observational study22
Dose–response effects of physical activity on all-cause mortality and major cardiorenal outcomes in chronic kidney disease21
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterizatio21
Association between change in cardiorespiratory fitness and incident hypertension in Swedish adults21
Electronic cigarettes and health with special focus on cardiovascular effects: position paper of the European Association of Preventive Cardiology (EAPC)21
Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study21
Impact of cardiorespiratory fitness on survival in men with low socioeconomic status21
Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts21
Cardiac patient care during a pandemic: how to reorganise a heart failure unit at the time of COVID-1920
Association between insulin resistance and risk of atrial fibrillation in non-diabetics20
Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patien20
Efficacy and safety of bempedoic acid in patients with hypercholesterolemia: A systematic review and meta-analysis of randomized controlled trials20
Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis20
Amiodarone as a possible therapy for coronavirus infection20
Joint association of physical activity and body mass index with cardiovascular risk: a nationwide population-based cross-sectional study20
Cardiac rehabilitation and all-cause mortality in patients with heart failure: a retrospective cohort study20
Gut microbiome and risk of ischaemic stroke: a comprehensive Mendelian randomization study19
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction19
The use of cardiac imaging in the evaluation of athletes in the clinical practice: A survey by the Sports Cardiology and Exercise Section of the European Association of Preventive Cardiology and Unive19
Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era19
Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors19
How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive19
Lessons learned from community- and home-based physical activity programs: A narrative review of factors influencing women’s participation in cardiac rehabilitation19
Combined aerobic/resistance/inspiratory muscle training as the ‘optimum’ exercise programme for patients with chronic heart failure: ARISTOS-HF randomized clinical trial19
Prediction of recurrent event in patients with coronary heart disease: the EUROASPIRE Risk Model19
Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioim19
The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank19
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease18
Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry18
Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction18
Addressing disparities of care in non-ST-segment elevation myocardial infarction patients without standard modifiable risk factors: insights from a nationwide cohort study18
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study18
How spaceflight challenges human cardiovascular health18
Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part 1: Supraventricular arrhythmias.18
Sinergy between drugs and devices in the fight against sudden cardiac death and heart failure18
Light to moderate coffee consumption is associated with lower risk of death: a UK Biobank study18
Rationale and design of two trials assessing the efficacy, safety, and tolerability of inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia18
Effect of coronavirus infection on the human heart: A scoping review18
Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies17
Comparison of Swiss and European risk algorithms for cardiovascular prevention in Switzerland17
Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study17
Vascular ageing: moving from bench towards bedside17
Left ventricular hypertrophy in athletes: How to differentiate between hypertensive heart disease and athlete’s heart17
Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990–201917
Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population17
Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study17
Cardiorespiratory fitness and survival following cancer diagnosis17
Sodium glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: a systematic review and meta-analysis17
The relationship between blood pressure and risk of atrial fibrillation: a Mendelian randomization study17
Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121 000 first-generation Asian immigrants16
Exploring the determinants of the cardiac changes after ultra-long duration exercise: The echocardiographic Spartathlon study16
Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism16
Risk of cardiovascular disease for women with polycystic ovary syndrome: results from a national Danish registry cohort study16
Sex differences in optimal medical therapy following myocardial infarction according to left ventricular ejection fraction16
Cardiovascular risk stratification by coronary computed tomography angiography imaging: current state-of-the-art16
Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 202916
Exercise-based cardiac rehabilitation vs. percutaneous coronary intervention for chronic coronary syndrome: impact on morbidity and mortality16
Menopause modulates the circulating metabolome: evidence from a prospective cohort study16
Association between ideal cardiovascular health and risk of sudden cardiac death and all-cause mortality among middle-aged men in Finland16
Increased awareness, inadequate treatment, and poor control of cardiovascular risk factors in American young adults: 2005–201616
Setting your clock: associations between timing of objective physical activity and cardiovascular disease risk in the general population16
The DASH diet is associated with a lower risk of heart failure: a cohort study16
Anticoagulation for atrial fibrillation in active cancer: what the cardiologists think16
Next-generation sequencing to confirm clinical familial hypercholesterolemia16
Sex differences on new-onset heart failure in patients with known or suspected coronary artery disease16
Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study16
Non-adherence to established dietary guidelines associated with increased mortality: the Copenhagen General Population Study16
The association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease in the UK Biobank16
Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry15
Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention15
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction15
Profile and management of hypertensive urgencies and emergencies in the emergency cardiology department of a tertiary hospital: a 12-month registry15
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy15
Risk stratification in cardiomyopathy15
Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus15
Diagnostic and prognostic value of low QRS voltages in cardiomyopathies: old but gold15
Time trends in ischaemic heart disease incidence and mortality over three decades (1990–2019) in 20 Western European countries: systematic analysis of the Global Burden of Disease Study 201915
Normative cardiopulmonary exercise data for endurance athletes: the Cardiopulmonary Health and Endurance Exercise Registry (CHEER)15
Acute effect of heat-not-burn versus standard cigarette smoking on arterial stiffness and wave reflections in young smokers15
Functional capacity assessment and Minimal Clinically Important Difference in post-acute cardiac patients: the role of Short Physical Performance Battery15
Taking the next steps to implement polygenic risk scoring for improved risk stratification and primary prevention of coronary artery disease15
High visit-to-visit cholesterol variability predicts heart failure and adverse cardiovascular events: a population-based cohort study15
Associations of genetic susceptibility and healthy lifestyle with incidence of coronary heart disease and stroke in individuals with hypertension15
Novel antidiabetic drugs and risk of cardiovascular events in patients without baseline metformin use: a meta-analysis15
Association between estimated pulse wave velocity and the risk of cardiovascular outcomes in men15
Biventricular mechanical pattern of the athlete’s heart: comprehensive characterization using three-dimensional echocardiography15
Athletes with valvular heart disease and competitive sports: a position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology14
Impact of environmental pollution and weather changes on the incidence of ST-elevation myocardial infarction14
Exercise intolerance and fatigue in chronic heart failure: is there a role for group III/IV afferent feedback?14
Novel prediction equation for appendicular skeletal muscle mass estimation in patients with heart failure: Potential application in daily clinical practice14
Incidence and prognosis of COVID-19 amongst heart transplant recipients: a systematic review and meta-analysis14
The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis14
ECG criteria for the detection of high-risk cardiovascular conditions in master athletes14
Influence of visceral adiposity accumulation on adverse left and right ventricular mechanics in the community14
Less revascularization in young women but impaired long-term outcomes in young men after myocardial infarction14
How do General Practitioners assess physical activity and prescribe exercise in patients with different cardiovascular diseases? An Italian pilot study14
Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors14
Association of pre-pregnancy cardiovascular risk factor burden with adverse maternal and offspring outcomes13
Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus13
Sex steroids and markers of micro- and macrovascular damage among women and men from the general population13
The role of cardiopulmonary exercise testing in predicting mortality and morbidity in people with congenital heart disease: a systematic review and meta-analysis13
Trends in blood pressure, blood lipids, and smoking from 259 753 patients with hypertension in a Swedish primary care register: results from QregPV13
Cardiovascular event rates increase after each recurrence and associate with poor statin adherence13
The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk13
The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithm of the 2017 ESC consensus statement: a simulatio13
Impact of bedtime dosing of antihypertensives compared to morning therapy: A meta-analysis of randomised controlled trials13
Comparison of MAGGIC and MECKI risk scores to predict mortality after cardiac rehabilitation among Dutch heart failure patients13
Global burden of rheumatic heart disease and its association with socioeconomic development status, 1990–201913
Low QRS voltages in Olympic athletes: Prevalence and clinical correlates13
Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis13
Optimising implementation of European guidelines on cardiovascular disease prevention in clinical practice: what is needed?13
Obesity, cardiovascular risk and healthcare resource utilization in the UK13
Clinical correlates and outcome of the patterns of premature ventricular beats in Olympic athletes: a long-term follow-up study13
Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials12
Association of periodic fasting lifestyles with survival and incident major adverse cardiovascular events in patients undergoing cardiac catheterization12
Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study12
Dipping pattern and short-term blood pressure variability are stronger predictors of cardiovascular events than average 24-h blood pressure in young hypertensive subjects12
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP12
Temporal trends and predictors of inhospital death in patients hospitalised for heart failure in Germany12
miR-181c level predicts response to exercise training in patients with heart failure and preserved ejection fraction: an analysis of the OptimEx-Clin trial12
High prevalence of physical inactivity after heart valve surgery and its association with long-term mortality: A nationwide cohort study12
‘Life’s Essential 8’ cardiovascular health with premature cardiovascular disease and all-cause mortality in young adults: the Kailuan prospective cohort study12
Age-dependent associations of body mass index with myocardial infarction, heart failure, and mortality in over 9 million Koreans12
Cardiovascular effectiveness of human-based vs. exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes12
Coronary heart disease incidence still decreased between 2006 and 2014 in France, except in young age groups: Results from the French MONICA registries12
High-density lipoprotein cholesterol and cardiovascular mortality: a prospective cohort study among 15.8 million adults12
Success factors in high-effect, low-cost eHealth programs for patients with hypertension: a systematic review and meta-analysis12
Epigenetics in the primary and secondary prevention of cardiovascular disease: influence of exercise and nutrition12
Prescribing, dosing and titrating exercise in patients with hypertrophic cardiomyopathy for prevention of comorbidities: Ready for prime time12
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: A systematic review and meta-analysis12
Extracellular vesicle species differentially affect endothelial cell functions and differentially respond to exercise training in patients with chronic coronary syndromes11
Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study11
Iron deficiency in heart failure—time to redefine11
A resilient type of familial hypercholesterolaemia: case–control follow-up of genetically characterized older patients in the SAFEHEART cohort11
Prevalence and extent of coronary artery calcification in the middle-aged and elderly population11
Familial occurrence of mitral regurgitation in patients with mitral valve prolapse undergoing mitral valve surgery11
Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study11
Cardiovascular disease in the elderly: proceedings of the European Society of Cardiology—Cardiovascular Round Table11
Management of complications of cardiac amyloidosis: 10 questions and answers11
Biventricular dysfunction and lung congestion in athletes on anabolic androgenic steroids: a speckle tracking and stress lung echocardiography analysis11
Next-generation sequencing to confirm clinical familial hypercholesterolemia11
Cardiac magnetic resonance in patients with muscular dystrophies11
Remnant cholesterol, low-density lipoprotein cholesterol, and incident cardiovascular disease among Koreans: a national population-based study11
Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities10
Impact of diabetes on coronary severity and cardiovascular outcomes in patients with heterozygous familial hypercholesterolaemia10
Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis10
Oxidative stress and inflammation in heart failure: The best is yet to come10
How to manage an athlete with mitral valve prolapse10
Profile and treatment of chronic coronary syndromes in European Society of Cardiology member countries: The ESC EORP CICD-LT registry10
2019 CORONAVIRUS: What are the implications for cardiology?10
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set10
Remnant cholesterol in patients admitted for acute coronary syndromes10
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association10
Platelet-to-hemoglobin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: A retrospective cohort study10
A window of opportunity on cardiovascular prevention: pre-eclampsia and fetal growth restriction10
0.070224046707153